| PERIOD ENDING | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 21,476 | 29,092 | 30,709 | 25,839 | | Cost of Revenue | 14,610 | 19,556 | 19,416 | 18,675 | | | Gross Profit | 6,865 | 9,536 | 11,293 | 7,164 | | | Operating Expenses | | Research Development | 3,151 | 3,120 | 4,068 | 3,753 | | Selling General and Administrative | 4,453 | 3,076 | 4,006 | 5,055 | | Non Recurring |
-
|
-
| (700) | 700 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (739) | 3,340 | 3,919 | (2,344) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,256 | (968) | (1,345) | 1,236 | | Earnings Before Interest And Taxes | 2,517 | 2,372 | 2,574 | (1,107) | | Interest Expense |
-
| 15 | 11 | 9 | | Income Before Tax | 2,517 | 2,357 | 2,563 | (1,116) | | Income Tax Expense | 269 | (17) | 390 | 208 | | Minority Interest |
-
| (86) | (235) | (208) | | | | Net Income From Continuing Ops | 2,100 | 1,812 | 1,498 | (1,674) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,100 | 1,812 | 1,498 | (1,674) | | Preferred Stock And Other Adjustments | (184) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,916 | $1,812 | $1,498 | ($1,674) |
|
0.91% Nasdaq 
Income Statement
